RPS19 and Diamond-Blackfan anemia: For our study, we selected only those variants for which there was no strong evidence of pathogenicity according to the genetic criteria outlined in Materials and Methods, and obtained 47 VUS reported in 122 patients (39% of RPS19‐mutated patients, approximately 10% of all DBA patients).